Botulinum toxin A (3.5 U/kg) decreases dural extravasation in IoNC injured rats. by Boris Filipović (336089)

Expression of Aβ42 decreases K_v4 protein and currents in the intact brain. by Yong Ping (233004)

No contribution of TGF-α, protein phosphatase 5 or protein kinase A to decreased levels of secreted Hsp90. by Stefan Tukaj (439533)

A+N_pFV decreases V_T, and reduces output of inspiratory muscles. by Robert T. R. Huckstepp (3391586)

The point mutation of <i>ERG251</i> leads to the partial dysfunction of <i>ERG251</i> causing acquisition of azole tolerance. by Xin Zhou (54275)

Induction of duodenal and hepatic Cyps in VD₃ deficient mice after DEX treatment. by Kavya Annu (11587215)

A nonsense mutation in <i>anmK</i> contributes to decreased growth of AC811 in Arabidopsis leaves. by Megan R. O’Malley (7485323)

Expression of <i>uvrC</i> is decreased in AC811 but not in Δ<i>gacA</i>-1. by Megan R. O’Malley (7485323)

Average DCE enhancement curves of control (A) and MCT (B) mice in each group pre- and post-chemo time points. by Mehran Baboli (8957807)

Plasma DEX concentrations in C57BL/6 VD₃ sufficient and deficient mice on a discontinuous DEX regimen. by Kavya Annu (11587215)

Doctors’ perceptions of the impact of upfront point-of-care testing in the emergency department by Lara Nicole Goldstein (6082706)

“…Upfront, protocolised, POC testing is a low-input, high-yield intervention that decreased treatment time and satisfied doctors.…”

Long COVID prevalence decreases with vaccine uptake, globally. by Manlio De Domenico (626037)

Long COVID prevalence decreases with vaccine uptake in the U.S. by Manlio De Domenico (626037)

Inhibition of ABCG2 decreases SP cells, but not sphere-forming ability. by Noriko Kawai (6694010)

Placental glucose transporter protein levels, fold changes and SD. by Vivi F. H. Jensen (12306563)

Suppression of endogenous human TRAM expression decreases R848 mediated <i>CCL5</i> and <i>IFN-β</i>, but not <i>TNF-α</i> expression. by Enda Shevlin (628477)

a-c: Bone marrow (BM) EPO receptor (EPO-R) decreases in uremic anemia rats. by Daniel Landau (440830)

“…<p>BM EPO-R protein (depicted as percentage of actin-corrected concentration) is unchanged in 7 day-bled rats Vs controls (Fig. 4a). Contrary to that BM EPO-R protein decreases in uremic (4 weeks after 5/6 nephrectomy) rats (Fig. 4b). …”

Demographic information of survey participants. by Katie J. Shillington (16557695)

“…A total of 2,188 participants were included in this study, with the majority of participants identifying as female (89.5%). …”

Cyp and transporter gene expression in duodenum of VD₃ sufficient and deficient mice. by Kavya Annu (11587215)

Expression of genes encoding proteins involved in protein folding, quality control, trafficking and ER-associated degradation differentially expressed in liver of <i>Fmo5</i><sup><... by Ian R. Phillips (5074121)